{"transactions":[{"id":2862065,"issuer":{"id":8336,"kind":"organization","name":"GRI Bio, Inc."},"owners":[{"id":142685,"kind":"organization","name":"SALMON Pharma GmbH","position":1,"cik":"0001843677","reported_name":"SALMON Pharma GmbH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-12T23:02:17.000Z","date":"2021-02-12","kind":"other","acquired":true,"shares":47063,"price":6.4,"value":301203.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021,  filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended."}],"balance_after":47063,"source":{"system":"sec-edgar","filing":"0001104659-21-022188","document":"tm214979-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824293/000110465921022188/tm214979-10_4seq1.xml","form_type":"4"}}]}